Pages not connected to items

Jump to navigation Jump to search

This page lists pages with no connected data item (in namespaces that support connected items). The list is sorted by descending page ID, so that newer pages are listed first.

 

Showing below up to 50 results in range #7,101 to #7,150.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of the Chinese Preventive Medicine Association, Zhonghua Liu Xing Bing Xue Za Zhi (2020) cited as Ref 18 in 10.1080/22221751.2020.1735265 (Q8438)
  2. Stephan F, et al, Respir Care (2017) cited as Ref 17 in 10.1080/22221751.2020.1735265 (Q8437)
  3. Cortegiani A, et al, Crit Care (2019) cited as Ref 16 in 10.1080/22221751.2020.1735265 (Q8436)
  4. Zhao H, et al, Crit Care (2017) cited as Ref 15 in 10.1080/22221751.2020.1735265 (Q8435)
  5. Branson RD, et al, Respiratory care equipment (1995) cited as Ref 14 in 10.1080/22221751.2020.1735265 (Q8434)
  6. Frat JP, et al, N Engl J Med (2015) cited as Ref 13 in 10.1080/22221751.2020.1735265 (Q8433)
  7. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, Zhonghua Liu Xing Bing Xue Za Zhi. (2020) cited as Ref 12 in 10.1080/22221751.2020.1735265 (Q8432)
  8. Stoecklin SB, et al, Euro Surveill (2020) cited as Ref 11 in 10.1080/22221751.2020.1735265 (Q8431)
  9. Silverstein WK, et al, Lancet (2020) cited as Ref 10 in 10.1080/22221751.2020.1735265 (Q8430)
  10. Kim JY, et al, J Korean Med Sci (2020) cited as Ref 9 in 10.1080/22221751.2020.1735265 (Q8429)
  11. Holshue ML, et al, N Engl J Med (2020) cited as Ref 8 in 10.1080/22221751.2020.1735265 (Q8428)
  12. Yu P, et al, J Infect Dis (2020) cited as Ref 7 in 10.1080/22221751.2020.1735265 (Q8427)
  13. Chan JF, et al, Lancet (2020) cited as Ref 6 in 10.1080/22221751.2020.1735265 (Q8426)
  14. Li Q, et al, N Engl J Med (2020) cited as Ref 5 in 10.1080/22221751.2020.1735265 (Q8425)
  15. Wang D, et al, JAMA (2020) cited as Ref 4 in 10.1080/22221751.2020.1735265 (Q8424)
  16. Chen N, et al, Lancet (2020) cited as Ref 3 in 10.1080/22221751.2020.1735265 (Q8423)
  17. Huang C, et al, Lancet (2020) cited as Ref 2 in 10.1080/22221751.2020.1735265 (Q8422)
  18. Zhou P, et al, Nature (2020) cited as Ref 1 in 10.1080/22221751.2020.1735265 (Q8421)
  19. Supplementary section of a publication (Q8420)
  20. Section or subsection level in publication (P148)
  21. Section 3.5.4: Glucocorticoid therapy (from DOI: 10.1080/22221751.2020.1735265)
  22. Disclosure statement (from DOI: 10.1080/22221751.2020.1735265) (Q8419)
  23. Section 5: Criteria of isolation release and discharge (from DOI: 10.1080/22221751.2020.1735265) (Q8418)
  24. Section 4: Protection and transfer (from DOI: 10.1080/22221751.2020.1735265) (Q8417)
  25. Section 3.5.6: Empirical antimicrobial therapy (from DOI: 10.1080/22221751.2020.1735265) (Q8416)
  26. Section 3.5.5: Intravenous immunoglobulin (from DOI: 10.1080/22221751.2020.1735265) (Q8415)
  27. Section 3.5.4: Glucocorticoid therapy (from DOI: 10.1080/22221751.2020.1735265) (Q8414)
  28. Section 3.5.3: Antiviral treatment (from DOI: 10.1080/22221751.2020.1735265) (Q8413)
  29. Section 3.5.2.2: The way of respiratory support (from DOI: 10.1080/22221751.2020.1735265) (Q8412)
  30. Section 3.5.2.1: Choice of oxygen therapy (from DOI: 10.1080/22221751.2020.1735265) (Q8411)
  31. Section 3.5.2: Oxygen therapy (from DOI: 10.1080/22221751.2020.1735265) (Q8410)
  32. Section 3.5.1: General treatment (from DOI: 10.1080/22221751.2020.1735265) (Q8409)
  33. Section 3.5: Treatment (from DOI: 10.1080/22221751.2020.1735265) (Q8408)
  34. Section 3.4.2: Critically ill type (from DOI: 10.1080/22221751.2020.1735265) (Q8407)
  35. Section 3.4.1: Severe type (from DOI: 10.1080/22221751.2020.1735265) (Q8406)
  36. Section 3.4: Place of treatment according to the severity of the disease (from DOI: 10.1080/22221751.2020.1735265) (Q8405)
  37. Section 3.3.2: Sequential examination of confirmed patients (from DOI: 10.1080/22221751.2020.1735265) (Q8404)
  38. Section 3.3.1: Screening cases on the day of visit (from DOI: 10.1080/22221751.2020.1735265) (Q8403)
  39. Section 3.3: Examination routines of SARS-CoV-2 infected patient (from DOI: 10.1080/22221751.2020.1735265) (Q8402)
  40. Section 3.2: Diagnostic criteria (from DOI: 10.1080/22221751.2020.1735265) (Q8401)
  41. Section 3.1: Screening criteria (from DOI: 10.1080/22221751.2020.1735265) (Q8400)
  42. Section 3: Diagnosis and treatment of SARS-CoV-2 infected patients (from DOI: 10.1080/22221751.2020.1735265) (Q8399)
  43. Section 2.3: Isolation and observation of medical personnel after close contact with SARS-CoV-2 (from DOI: 10.1080/22221751.2020.1735265) (Q8398)
  44. Section 2.2: Isolation and protection requirements (from DOI: 10.1080/22221751.2020.1735265) (Q8397)
  45. Section 2.1: Selection of front-line personnel (from DOI: 10.1080/22221751.2020.1735265) (Q8396)
  46. Section 2: Protection requirements of medical personnel (from DOI: 10.1080/22221751.2020.1735265) (Q8395)
  47. Section 1: Introduction (from DOI: 10.1080/22221751.2020.1735265) (Q8394)
  48. Taisheng Li (1st author of DOI 10.1080/22221751.2020.1735265) (Q8389)
  49. Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0) (DOI: 10.1080/22221751.2020.1735265) (Q8388)
  50. No cited references in this section (Q8386)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://wikibase.slis.ua.edu/wiki/Special:UnconnectedPages"